Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

3results about How to "New structure" patented technology

New glycosides from Momordica cochinchinensis, their preparation and application

ActiveCN117820509Bhigh puritynew structure
A class of novel mubezhiside compounds, their preparation, and applications, including: mubezhiside A and mubezhiside B. This invention removes impurities directly via macroporous lipid column chromatography after boiling in water, simultaneously removing both aqueous and lipid-soluble impurities with high efficiency. Following impurity removal, silica gel column chromatography is used for purification, allowing for significantly larger sample loading and shorter processing time compared to ODS column chromatography. Preparative HPLC is employed for final purification, greatly improving the purification effect.
Owner:SHANGHAI JIAOTONG UNIV

A [3]rotaxane luminescent material with aggregation-induced emission property and a preparation method and application thereof

PendingCN122541270ARich molecular librarynew structure
This invention relates to the field of aggregation-induced emission materials, specifically to a [3]-axylene luminescent material with aggregation-induced emission properties, its preparation method, and its applications. This invention is the first to combine the [3]-axylene core structure with aggregation-induced emission characteristics, providing a novel class of AIE molecules, enriching the molecular library of AIE materials, and possessing potential application value in chemical sensing, optoelectronics, biological fluorescent probes, and bioimaging.
Owner:THE CHINESE UNIV OF HONG KONG (SHENZHEN)

Yohimbine derivatives, their preparation methods and uses

PendingCN122325465Anew structureimportant scientific basisAdrenergicUlcerative colitis
Yohimbine derivatives, their preparation methods, and uses. This invention discloses compounds of Formula I and pharmaceutical compositions comprising compounds of Formula I. The compounds of Formula I of this invention, as adrenaline receptor α2A (ADRA2A) antagonists or partial antagonists, can treat and / or prevent inflammatory bowel disease (IBD), particularly ulcerative colitis (UC), Crohn's disease (CD), or enteritis.
Owner:IBIOME BIOTECHNOLOGY CO LTD